Pricing Log in Create free account
Friday 6 November 2026 Export DGX’s income statement to Excel — free account

Quest Diagnostics Incorporated

DGX Healthcare Diagnostics & Research

Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024.

Revenue
+9.98%
EPS
+29.4%
Free cash flow
+6.21%
Total debt
−2.20%

Quarter to September 2026, against a year earlier

254.25 1.43 −0.56%
Market cap
$28.0B
P/E
25.0×
Fwd P/E
24.4×
Dividend yield
1.33%
F-score
8/9
Altman Z
3.15
Beneish M
−2.65
Dividend safety
85/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Quest Diagnostics Incorporated (DGX) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Quest Diagnostics Incorporated (DGX) trades at a EV/Sales of 2.8×. Over the past ten years it has ranged from 1.6× (September 2015) to 2.8× (September 2026); the current reading is higher than 99% of that period. That is below the Diagnostics & Research industry median of 5.2× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.2× (2.16%)
FY2024 2.3× 6.09%
FY2023 2.1× (2.69%)
FY2022 2.2× (4.20%)
FY2021 2.3× 15.08%
FY2020 2.0× (13.84%)
FY2019 2.3× 15.60%
FY2018 2.0× (13.79%)
FY2017 2.3× 2.71%
FY2016 2.3× 23.16%

Quarterly newest first

Period EV/Sales Change
Sep 2026 2.6× 3.95%
Jun 2026 2.5× 3.82%
Mar 2026 2.4× 7.06%
Dec 2025 2.2× (9.35%)
43 more quarters

Against its own ten years

Low 1.6× High 2.8×
Ten-year median 2.2×
Current reading's percentile 99

EV/Sales against peers

Company EV/Sales
LH Labcorp Holdings Inc. compare 2.4×
DGX Quest Diagnostics Incorporated 2.8×
IQV IQVIA Holdings Inc. compare 3.3×
MEDP Medpace Holdings, Inc. compare 6.0×
RVTY Revvity Inc. compare 6.6×
ILMN Illumina, Inc. compare 7.2×
MTD Mettler-Toledo International, Inc. compare 8.7×
WAT Waters Corporation compare 8.7×
GH Guardant Health, Inc. compare 16.6×
Diagnostics & Research industry median 5.2×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on DGX